Researchers at Kumamoto University have demonstrated that iron supplementation can significantly alleviate muscle pathology ...
FDA has requested the HOPE-3 clinical study report (CSR) as part of the BLA review processCompany expects to submit updates ...
Researchers at Kumamoto University have demonstrated that iron supplementation can significantly alleviate muscle pathology and functional decline in a mouse model of facioscapulohumeral muscular ...
Capricor Therapeutics (CAPR) shares are back in focus after the company reported an FDA update on its Biologics License Application for Deramiocel, its cell therapy candidate for Duchenne muscular ...
“MAID gave me the freedom to determine my own fate,” said Jeremy Boal ...
As biotechs faced investors at the J.P. Morgan Healthcare Conference this week, they emphasized agreement with the FDA on ...
Chinese scientist He Jiankui, who served prison time for creating the world's first gene-edited babies, is planning to repeat ...
Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...
Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.
What the medical literature suggests on who and what might benefit from creatine supplementation and what's less clear.
Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, announces that ...
The U.S. Food and Drug Administration has awarded orphan drug status to Atossa Therapeutics' (Z)-endoxifen for Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results